July 05, 2009
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for November 7, 2007 Subscribe to this News Feed  
 

Beverly Hills Medical Director Urges Using Botox to Cure Women’s Cancer as Part of November Fundraiser

Download this press release as an Adobe PDF document.

Epione’s Botox to Cure Women's Cancer effort in Beverly Hills will take the growing trend of women and men being treated with BOTOX® Cosmetic in the United States and turn it into a philanthropic call to action to find a cure for women’s cancer.

Beverly Hills, Calif. (PRWEB) November 7, 2007 -- A unique Beverly Hills fundraising event will turn Botox profits into financial support for the battle against cancer, say event organizers Epione Beverly Hills and Medical Director Dr. Simon Ourian. In November, a percentage of all BOTOX® Cosmetic profits will be donated to organizations dedicated to finding cures for breast and ovarian cancer by Epione Beverly Hills and Allergan, Inc.

Botox to Cure Women's Cancer project will take the growing trend of women and men being treated with BOTOX® Cosmetic in the United States and turn it into a philanthropic call to action to find a cure for women’s cancer.

I have family and loved ones who have been touched by cancer. I plan to do this every November until the day it will no longer be necessary
According to the American Cancer Society, an estimated 678,000 new cases of cancer will be diagnosed among women in 2007. The chance of developing invasive breast cancer at some time in a woman's life is about 1 in 8 (12%). It is estimated that in 2007 about 178,480 new cases of invasive breast cancer will be diagnosed among women in the United States. The American Cancer Society estimates that about 22,430 new cases of ovarian cancer will be diagnosed in the United States during 2007.

Allergan, Inc. has agreed to donate BOTOX Cosmetic® for this event, and Dr. Ourian and his Beverly Hills staff will be donating their time and expertise for this worthwhile cause. Dr. Ourian has opted to initiate this effort because of his extensive experience in the use of BOTOX® Cosmetic to reduce frown lines and facial wrinkles.

"I have family and loved ones who have been touched by cancer. I plan to do this every November until the day it will no longer be necessary,” said Dr. Ourian.

More information on cancer and other diseases directly effecting women can be found at The National Women's Health Information Center (NWHIC), the most reliable and current information resource on women’s health today. It offers free women’s health information on more than 800 topics through its call center and Web site: www.womenshealth.gov.

About Epione™ Medical Corporation
Dr. Ourian’s Epione™ Medical Corporation is located in Beverly Hills “Golden Triangle” and is among the world’s most comprehensive and state-of-the-art laser and cosmetic surgery centers. Epione™ provides the most current technology for skin, hair, noninvasive facelift procedures and body contouring. Dr. Ourian is a pioneer for laser technology and aesthetic procedures for acne, wrinkle reduction, skin discoloration, and facial rejuvenation. In November, Epione plans to organize the Botox to Cure Women’s Cancer project, which will turn botox profits into financial support for the battle against cancer. For further information, call Epione™ at (888) 951-3377 or visit http://www.epione.com.

###

Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1TaW5nLVpldGEtWmV0YS1UaGlyLVplcm8=


See the original story at: http://www.prweb.com/releases/Beverly_Hills/Botox/prweb567830.htm
Other Releases by this Member
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
David Ehrlich
Epione Medical Corporation
310-271-6506
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright